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INTRODUCTION
 Cardiovascular disease (CVD) is highly prevalent 
in South Asia, and is one of the leading causes of 
mortality. South Asians tend to develop myocardial 
infarction (MI) at a younger age compared to other 
countries, and the mortality rates due to MI are 
expected to continue rising in the future.1
	 Vitamin	 D	 deficiency	 has	 been	 shown	 to	 be	
an	 independent	 risk	 factor	 for	 CVD,	 with	 the	
risk	 varying	 inversely	 with	 the	 serum	 levels	 of	
vitamin D.2-4	However,	this	association	varies	with	
race	 and	 may	 not	 be	 generalizable	 to	 all	 ethnic	
groups.5	Vitamin	D	deficiency	 is	 highly	prevalent	
in	 Pakistan,	 with	 around	 85%	 of	 the	 population	
having	 insufficient	 or	 deficient	 serum	 vitamin	 D	
levels.6,7	However,	except	for	one	small	study,	there	
has	been	hardly	any	report	on	association	of	vitamin	
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Association of Vitamin D deficiency and VDBP gene 
polymorphism with the risk of AMI in a Pakistani population
Mujtaba Mubashir1, Shaheena Anwar2, Asal Khan Tareen3,
Naseema Mehboobali4, Khalida Iqbal5, Mohammad Perwaiz Iqbal6
ABSTRACT
Objective: To investigate the relationship of vitamin D deficiency and risk of AMI in a Pakistani population, 
and to find out any association between vitamin D binding protein (VDBP) genotypes and risk of AMI in this 
population.
Methods: In a comparative cross-sectional study, 246 patients (age: 20-70 years; 171 males and 75 females) 
with first AMI were enrolled with informed consent. Similarly, 345 healthy adults (230 males and 115 
females) were enrolled as controls. Their fasting serum samples were analyzed for 25 (OH) vitamin D, 
lipids and other biomarkers using kit methods, while DNA was analyzed for VDBP genotypes using PCR-RFLP 
based methods. Chi-squared test and logistic regression were used for association of vitamin D deficiency 
and VDBP genotypes with AMI.
Results: Mean serum concentration of 25(OH) vitamin D was significantly lower in AMI patients compared 
to healthy subjects (p=0.015) and percent vitamin D deficiency was higher in AMI patients compared to 
healthy subjects (p=0.003). VDBP IF-IF genotype was positively associated with the risk of AMI in subject 
above 45 years after adjusting for potential confounders [OR = 9.86; 95% CI=1.16 to 83.43].
Conclusion: Vitamin D deficiency and VDBP IF-IF genotype are associated with AMI in Pakistani adults. 
KEYWORDS: Acute myocardial infarction, Coronary heart disease, Pakistani population, Vitamin D binding 
protein genotypes, Vitamin D deficiency.
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D	 deficiency	 and	 the	 risk	 of	 acute	 myocardial	
infarction (AMI) in the Pakistani population.8 
Therefore, it is imperative to investigate the 
relationship	between	vitamin	D	deficiency	and	risk	
of AMI in the Pakistani population using a large 
sample	size.
	 Vitamin	D	is	transported	in	blood	bound	mainly	
to	vitamin	D	binding	protein	(VDBP),	also	known	
as	Group-specific	 component	 (Gc).	 VDBP	 is	 a	 55-
kd	 protein	 encoded	 by	 the	 Gc	 gene,	 located	 on	
chromosome 4.9,10 There exist three major alleles 
encoding	 VDBP	 (Gc-1F,	 Gc-1S	 and	 Gc-2)	 that	
combine	to	form	6	major	genotypes,	namely,	1F-1F,	
1F-1S,	1S-1S,	1S-2,	1F-2,	and	2-2.9 These genotypes 
have	variable	frequencies	in	populations	of	different	
ethnic	backgrounds	and	have	different	affinities	for	
binding	vitamin	D	in	the	circulation.9
	 Few	 studies	 have	 explored	 the	 role	 of	 VDBP	
genotypes	 as	 potential	 risk	modifiers	 of	 coronary	
heart disease (CHD). Some of these studies revealed 
no	effect	of	the	VDBP	genotype	distribution	on	the	
risk of developing CHD in some of the Western 
populations.11,12	 However,	 no	 studies	 have	 been	
carried out on South Asian population to investigate 
this relationship.
	 Our	study	aimed,	firstly,	 to	 identify	whether	an	
association	exists	between	serum	levels	of	vitamin	
D and the risk of developing AMI in a Pakistani 
population,	 and	 secondly,	 whether	 there	 is	 an	
association	 between	 VDBP	 genotypes	 and	 risk	 of	
developing	 AMI	 in	 a	 hospital	 based	 Pakistani	
population.
METHODS
Participants: 591	 individuals	 were	 enrolled	
(with	 informed	 consent)	 into	 this	 comparative	
cross-sectional	 study	 of	 which	 246	 were	 patients	
who	 had	 recently	 suffered	 an	AMI	 and	 345	were	
healthy	 subjects.	 The	 AMI	 patients	 were	 selected	
from the National Institute of Cardiovascular 
Diseases	(NICVD)	Karachi	from	September	2011	to	
December	2014.	They	were	diagnosed	with	AMI	as	
per	the	revised	WHO	classification.13	Subjects	were	
excluded	from	the	study	 if	 they	were	 less	 than	20	
years or more than 70 years old, if they had taken 
vitamin D supplementation during the last six 
months,	 if	 they	 were	 pregnant	 or	 suffering	 from	
chronic diseases including uremia, cancer and liver 
disease.	 The	 healthy	 subjects	 were	 selected	 from	
the staff of the Aga Khan University (AKU) and 
NICVD	based	on	the	same	criteria	and	functioned	
as	controls.	This	study	was	approved	by	the	Ethics	
Review	Committee	of	AKU.	
Measurement of serum biomarkers: Serum levels 
of 25(OH) vitamin D [25(OH)D], lipids, calcium, 
phosphate, and alkaline phosphatase (ALP) of the 
enrolled	 participants	 were	 determined	 using	 an	
automated	kit	method	(Elecsys,	Roche	Diagnostics,	
Indianapolis).	The	serum	25(OH)	D	levels	were	then	
categorized	 as	 deficient	 (<	 20	 ng/ml),	 insufficient	
(20-29.9	ng/ml)	or	sufficient	(≥	30	ng/ml).		
Genotyping: DNA	 for	 genotyping	 was	 extracted	
from	 white	 blood	 cells	 obtained	 from	 the	 study	
subjects	 using	 a	 standard	 salting	 out	 method.	
Polymerase	 Chain	 Reaction	 (PCR)	 was	 used	 to	
amplify	 the	 region	 of	 interest	 of	 the	 VDBP	 gene	
using	the	method	of	Ito	et	al	that	has	been	described	
in	detail	in	a	previous	publication.14,15 
	 The	resulting	PCR	product	(462	bp)	was	digested	
separately	 with	 the	 restriction	 enzymes,	 HaeIII	
and	Styl-HF	 following	 the	principle	of	Restriction	
Fragment	 Length	 Polymorphism	 (RFLP).	 The	
digested	 PCR	 products	 were	 then	 run	 on	 a	 3%	
agarose	 gel	 containing	 ethidium	 bromide,	 and	
VDBP	 genotypes	 were	 visualized	 as	 described	
previously.15
Statistical analysis: Baseline	 characteristics	 and	
mean	 serum	 vitamin	 D	 levels	 of	 both	 the	 AMI	
patients	and	healthy	controls	were	reported	as	mean	
±	SD	and	interquartile	ranges,	and	compared	using	
independent	 sample	 t-test.	 Frequencies	 of	 VDBP	
genotypes	were	tabulated	and	the	Hardy	Weinberg	
model	 was	 used	 to	 determine	 the	 frequencies	 of	
the corresponding alleles and diplotypes. Chi-
squared	test	was	used	to	compare	vitamin	D	status	
in	 AMI	 patients	 and	 healthy	 subjects	 groups.	
Multiple	 logistic	 regression	 was	 used	 to	 identify	
any	association	between	VDBP	genotypes	and	the	
risk of developing AMI, using the most common 
genotype (1S-1S) as reference value. The model 
was	adjusted	for	age,	gender,	BMI,	serum	LDL	and	
vitamin D levels in order to account for potential 
confounders.	SPSS	(version	19)	was	used	for	all	data	
analyses	and	p≤0.05	was	considered	significant.
RESULTS
 The	 baseline	 serum	 levels	 of	 cholesterol,	 LDL,	
HDL,	 ALP	 and	 calcium	 differed	 significantly	
between	 the	 AMI	 patients	 and	 healthy	 controls	
(Table-I).	 	 Moreover,	 28%	 of	 AMI	 patients	 were	
suffering	from	type	2	diabetes	mellitus,	while	none	
of the healthy controls had it.  Nearly half of the AMI 
patients	(46%)	had	hypertension,	while	only	4%	of	
the controls suffered from this condition. Mean 
serum	 concentration	 of	 25(OH)	 D	 was	 13.5±14.0	
ng/ml	 in	 AMI	 patients	 which	 was	 significantly	
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lower	than	the	mean	concentration	16.1±11.7	ng/ml	
in	healthy	subjects	(p=0.015).	Vitamin	D	deficiency	
(<20	ng/ml)	was	highly	prevalent	among	the	study	
participants	 in	 both	 the	 groups	with	 83.0%	of	 the	
AMI	 patients	 and	 70.6%	 of	 the	 healthy	 controls	
classified	 as	 vitamin	 D	 deficient	 (Table-II).	 There	
was	 an	 association	 between	 vitamin	D	 deficiency	
and	AMI	in	this	population	(p=0.003).
Genotyping: 227	 AMI	 patients	 and	 300	 healthy	
controls	were	genotyped.	The	frequency	distribution	
of	VDBP	alleles,	diplotypes	and	genotypes,	shown	
in	 Table-III,	 was	 in	 accordance	 with	 the	 Hardy	
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Table-I:	Baseline	demographics,	and	serum	biomarker	concentrations	in	AMI	patients	and	healthy	subjects.
Characteristics* AMI patients (n=246) Healthy subjects (n=345) p-value**
Gender,	n	(%)
Male 171(69.5) 230(66.7) 0.46
Female 75(30.5) 115(33.5) 0.46
Mean	±	SD/	IQR	(Median) Mean	±	SD/IQR	(Median)
Age (years) 43.6±8.0/	44(5) 42.8±7.7/43(5) 0.35
BMI	(kg/m2) 24.8±4.2/25.0(4.8) 25.7±4.8/25.3(5.7) 0.04
Cholesterol	(mg/dl) 152.4±	6.1/150(66) 173.4±37.4/171(46) <0.01
Triglycerides	(mg/dl) 163.7±84.7/145(88) 151.0±88.9/132(90) 0.13
LDL-cholesterol	(mg/dl) 97.6±39.4/94(54) 108.4±33.9/107(47) <0.01
HDL-cholesterol	(mg/dl) 28.3±11.2/27(11) 38.1±8.3/37(11) <0.01
Phosphate	(mg/dl) 3.8±0.9/3.7(1.0) 3.9±2.0/3.7(0.8) 0.50
Calcium	(mg/dl) 8.4±1.1/8.6(1.1) 8.9±1.2/9(1.2) <0.01
Alkaline	phosphatase	(U/I) 67.1±30.1/63(31) 75.0±54.3/69.0(27) 0.05
25(OH)D	(ng/ml) 13.5±14.0/10.0(11.3) 16.1±11.7/13.5(14.4) 0.015
*Data	are	presented	as	the	number	of	patients	(percentage)	or	Mean	±	standard	deviation/	Interquartile	Range	(Median).	
**p-value	was	obtained	by	comparing	mean	values	in	two	groups	using	Independent	sample	t-test.
Table-II:	Vitamin	D	status	on	the	basis	of	mean	 
serum concentration of 25 (OH) vitamin D 
in	AMI	patients	and	healthy	subjects.
Vitamin D status
[(25(OH)D 
concentration]
AMI 
patients 
(n=246)
n (%)
Healthy 
subjects 
(n=345)
n (%)
p-value*
Deficient	
(<20	ng/ml)
203(83.0) 240(70.6)
0.003
Insufficient	
(20-29.9	ng/ml)
26(10.6) 66(19.4)
Sufficient	
(≥30	ng/ml)
16(6.5) 34(10.0)
*p-value	was	obtained	using	Chi-squared	test	comparing	
percentages	in	both	the	groups.
Table-III:	Frequency	distribution	of	VDBP	alleles,	
diplotypes and genotypes in AMI patients
and	healthy	subjects.
VDBP
AMI patients 
(n=227)
n (π)
Healthy 
controls 
(n=300)
n (π)
Allele
1F 96(0.21) 106(0.17)
1S 239(0.52) 332(0.55)
 2 119(0.26) 162(0.27)
Diplotype
Gc 1-1 124(0.55) 162(0.54)
Gc 1-2 87(0.38) 114(0.38)
Gc 2-2 16(0.07) 24(0.08)
Genotype
1F-1F 12(0.05) 4(0.01)
1S-1S 67(0.29) 94(0.31)
2-2 16(0.07) 24(0.08)
1F-1S 45(0.20) 64(0.21)
1F-2 27(0.12) 34(0.11)
1S-2 60(0.26) 80(0.26)
HWE	p a 0.996 0.990
a p-value was	obtained	using	 the	Hardy	Weinberg	
equilibrium.
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Weinberg	 equilibrium	 (HWE)	 in	 both	 the	 groups.	
In	both	AMI	patients	and	healthy	controls,	Gc	1S-
1S	 was	 found	 to	 be	 the	 most	 common	 genotype	
(29%	&	31%),	while	Gc	1F-1F	was	the	least	common	
genotype	 (5%	&	 1%).	 To	 evaluate	 the	 association	
of	 VDBP	 genotypes	 with	 AMI,	 	 multiple	 logistic	
regression	 was	 performed,	 which	 revealed	 that	
the	 Gc1F-1F	 genotype	 was	 positively	 associated	
with	 the	 risk	 of	 AMI	 in	 persons	 above	 45	 years	
after	adjusting	 for	vitamin	D	 levels,	gender,	body	
mass	 index	 (BMI)	 and	LDL	 [odds	 ratio=9.86;	 95%	
confidence	interval=1.16	to	83.43;	Table-IV].
DISCUSSION
 Our	 study	 showed	 that	 vitamin	D	deficiency	 is	
highly	prevalent	 in	this	Pakistani	population	with	
75.7%	of	all	study	participants	classified	as	vitamin	
D	deficient.	This	figure	is	consistent	with	previous	
estimates	of	the	prevalence	of	vitamin	D	deficiency	
in this region.6,7
	 An	 association	was	 found	 between	 the	 vitamin	
D	 deficiency	 and	 development	 of	 AMI;	 vitamin	
D	 deficiency	was	more	 common	 in	 AMI	 patients	
compared to healthy controls. Recent studies in the 
region	 exploring	 the	 role	 of	 vitamin	D	 deficiency	
in	CVD	have	shown	an	association	between	severe	
vitamin	 D	 deficiency	 and	 the	 risk	 of	 AMI	 after	
adjusting for conventional risk factors,4,8	 while	
others	 have	 shown	 that	 this	 risk	 varies	 inversely	
with	serum	vitamin	D	levels.2	 	Robinson-Cohen	et	
al.	have	reported	that	this	association	varies	by	race,	
such	that	it	is	not	found	in	Blacks	and	Hispanics.5 In 
a recent meta-analysis, Huang et al have concluded 
that	 25(OH)D	 levels	 were	 significantly	 lower	 in	
MI	 patients	 in	 America	 and	 Asia	 and	 sufficient	
levels	of	vitamin	D	could	be	protective	against	the	
occurrence of MI.16 Malik et al have found vitamin D 
deficiency	to	be	more	severe	in	Indian	patients	with	
MI compared to controls.17 Our data add support 
to	 all	 these	 findings	 that	 this	 association	 holds	
true	 in	 the	South	Asian	population,	with	analyses	
showing	that	sufficient	blood	25(OH)D	levels	was	
a protective factor for MI in this population.4,16,17 
Thus,	low	serum	vitamin	D	level	is	an	important	but	
often overlooked aspect of cardiovascular disease. 
The	possible	reason	for	this	association	of	vitamin	
D	 deficiency	 with	 AMI	 merits	 some	 discussion.	
Low	 serum	 levels	 of	 vitamin	D	 often	 accompany	
high	 levels	 of	 parathyroid	 hormone	 which	 has	
been	shown	to	mediate	cardiovascular	events,	such	
as cardiac hypertrophy, vascular remodeling and 
inflammation.18	 Moreover,	 lower	 serum	 levels	 of	
25(OH)	D	 have	 been	 found	 to	 be	 associated	with	
reduced serum levels of HDL, increased triglyceride 
levels and elevated atherogenic index of plasma.19 
These factors could lead to the development of AMI 
in hypovitaminosis D.
 Our study also revealed an increased risk of AMI 
in	 individuals	 with	 the	 VDBP	 genotype	 Gc	 1F-
1F,	 especially	 in	 those	 above	 the	 age	 of	 45	 years,	
after adjusting for confounders. Previous studies 
revealed	no	effect	of	VDBP	genotype	distribution	on	
the risk of CHD.11,12	These	findings	can	be	explained	
by	 the	 fact	 that	 these	 studies	 were	 conducted	 on	
non-Asian populations and thus may not apply 
to Asian populations due to ethnic variations in 
the	 frequency	 distribution	 of	 VDBP	 genotypes.20 
Our	 study	 is	 the	 first	 large	 study	 to	 report	 the	
association	of	 vitamin	D	deficiency	 and	AMI	 in	 a	
Pakistani	population.		It	is	also	unique	in	reporting	
Gc	1F-1F	genotype	as	a	risk	 factor	 for	AMI,	albeit	
in	the	Pakistani	population.	Gc	1F-1F	has,	however,	
been	shown	to	play	an	important	role	in	a	number	
of	non-communicable	diseases.21
	 A	 number	 of	 studies	 have	 been	 carried	 out	 to	
investigate	the	relationship	of	VDBP	polymorphism	
with	vitamin	D	deficiency	and	CVD.		For	example	
in	 a	 recent	 review	 article,	 it	 has	 been	 reported	
that	VDBP	polymorphism	may	 affect	 the	 binding	
affinity	 for	vitamin	D,	 thereby,	 increasing	 the	risk	
of	 vitamin	 D	 deficiency	 and	 other	 CVDs.22	 Lafi	
et	 al	 have	 also	 reported	 an	 association	 of	 VDBP	
polymorphism	 with	 increased	 risk	 of	 vitamin	
D	 deficiency	 among	 healthy	 Jordanians.23  On 
the	 other	 hand,	 Michos	 et	 al	 showed	 that	 low	
serum	 levels	 of	 25(OH)D	 were	 associated	 with	
increased incidence of CHD among Whites, 
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Table	IV:	Association	of	VDBP	genotypes	
with	risk	of	AMI	in	Pakistani	adults.
VDBP 
genotype
Crude OR
(95% CI)
Adjusted OR†
(95% CI)
1S-1S* 1 1
1F-1F 4.20(1.30-13.6) 9.86(1.16-83.43)*
2-2 0.90(0.46-1.90) 1.1(0.50-2.42)
1F-1S 0.98(0.60-1.61) 0.93(0.51-1.70)
1F-2 1.20(0.61-2.01) 1.03(0.20-2.13)
1S-2 1.03(0.66-1.66) 1.21(0.67-2.16)
*Most common genotype taken as reference value
†	Adjusted	for	age	(<45years,	>45	years),	gender	and	
vitamin	D	levels,	BMI	and	LDL
Note: OR	is	odds	ratio,	while	CI	stands	for	confidence	
interval.
however,	 no	 interaction	 of	 25(OH)D	 levels	 with	
VDBP	 genotypes	 was	 found	 in	 that	 population.11 
Similarly,	 VDBP	 genetic	 variants	 were	 not	 found	
to	 be	 related	 with	 CHD	 in	 Italian	 population.24 
VDBP,	 in	 addition	 to	 its	 relationship	 with	 CHD	
through	vitamin	D	deficiency,	has	been	 shown	 to	
play a relatively direct role in the development of 
this disease. There are several lines of evidence in 
this	 regard	 and	 various	 mechanisms	 have	 been	
proposed. Rocchiccioli et al have reported that 
the	plasma	 concentration	of	VDBP	 is	 significantly	
higher in atherosclerotic patients compared to 
healthy	subjects.25 VDBP	expression	increases	with	
endothelial stress, and this differential expression 
regulates	 the	 formation	 of	 neointima	 in	 blood	
vessels	by	altering	the	proliferation	and	migration	
of vascular smooth muscle cells.26 This is further 
supported	 by	 proteomics-based	 studies	 showing	
higher	levels	of	VDBP	in	thrombi	of	patients	with	
acute myocardial infarction compared to control 
subjects.27 VDBP	 also	 plays	 an	 important	 role	 in	
tissue	 injury	 by	 its	 conversion	 to	 macrophage-
activating	 factor	 (VDBP-MAF)	 as	 well	 as	 by	
scavenging for vascular and extracellular actin.27,28 
Macrophages play a critical role in the development 
of atherosclerosis and ultimately coronary heart 
disease.29	Diabetes	mellitus	is	also	closely	linked	to	
atherosclerosis, and hence studies have explored 
the	 role	of	VDBP	expression	 in	diabetes	 as	well.28 
VDBP	 polymorphism	 was	 associated	 with	 an	
increased	susceptibility	to	type	2	diabetes	mellitus	
in	Asians,	while	this	association	did	not	hold	true	
in	 European	 populations.30	 This	 could	 be	 one	 of	
many	factors	explaining	why	the	burden	of	MI	and	
diabetes	is	so	high	in	South	Asian	population.1
	 In	the	present	study,	we	identified	12	cases	which	
had none of the classical risk factors for CHD such 
as	 hypertension,	 diabetes,	 smoking,	 high	 BMI,	
dyslipidemia, history of ischemic heart disease in 
parents.	 	However,	when	 the	percentages	of	 their	
VDBP	genotypes	were	compared	with	percentages	
of	 genotypes	 of	 those	 AMI	 patients	 with	 one	 or	
more	classical	risk	factors	using	chi	square	test,	no	
statistically	 significant	 difference	 was	 found	 (p	 =	
0.396;	data	not	shown)	suggesting	that	in	the	absence	
of	 classical	 risk	 factors,	 VDBP	 polymorphism	
alone	does	not	appear	 to	be	associated	with	AMI.	
However,	conclusive	evidence	can	only	be	obtained	
using	a	large	sample	size	of	AMI	patients	with	no	
classical risk factor for CVD.
Limitations of the Study: There are certain 
limitations	 of	 our	 study.	 The	 Gc1F-1F	 genotype	
is the least common genotype encountered in the 
Pakistani population as seen in our study and hence 
a	 larger	 sample	 size	 of	 individuals	 carrying	 this	
genotype	 needs	 to	 be	 studied	 in	 order	 to	 further	
validate	our	findings.	Moreover,	surveys	need	to	be	
carried out in different parts of the country to study 
the	 effect	 of	 this	 genotype	 in	 ethnic	 backgrounds	
not represented in the present study. 
 The present study also has some strength. AMI 
patients	 were	 sampled	 from	 NICVD,	 Karachi	 to	
ensure	that	the	study	sample	resembled	the	general	
population closely in terms of socioeconomic 
backgrounds	and	ethnic	groups.	Seasonal	variations	
in	vitamin	D	levels	were	accounted	for	by	selecting	
both	 AMI	 patients	 and	 healthy	 controls	 all	 year	
across.	Confounding	variables	were	accounted	for	
in	data	analysis.	This	study	is	among	the	very	few	
that	have	explored	the	role	of	VDBP	genotypes	in	
AMI	patients	and	adds	 to	 the	body	of	knowledge	
on	this	subject.
	 In	terms	of	public	health	policy,	this	study	raises	
several issues. As CVD is highly prevalent in our 
society	and	remains	a	growing	cause	of	morbidity	
and	 mortality,	 vitamin	 D	 deficiency	 needs	 to	
be	 addressed	 as	 an	 important	 modifiable	 risk	
factor	 that	 could	 alleviate	 the	 burden	 of	 disease.	
Whether	 this	 risk	 can	 be	 alleviated	 by	 vitamin	D	
supplementation	in	deficient	individuals	is	not	yet	
certain,	however,	several	clinical	trials	are	currently	
underway	to	address	this	question.31
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